Literature DB >> 7977961

A prospective longitudinal study on radiation-induced hearing loss.

L J Anteunis1, S L Wanders, J J Hendriks, J A Langendijk, J J Manni, J M de Jong.   

Abstract

Recent clinical reports indicate that patients receiving radiotherapy that includes the auditory system in the treatment volume are likely to develop an irradiation-induced hearing loss. Although the early, presumed reversible, conductive hearing impairment due to secretory otitis media following radiotherapy is a sequela well known by radiation oncologists, permanent hearing loss, both conductive and sensorineural, is believed to be rare. A prospective study was performed enrolling patients receiving postoperative radiotherapy for unilateral parotid tumors. Audiometric results prior to irradiation were compared with those obtained 2 years later. Up to 50% of the patients (9 of 18) developed a clinically relevant hearing loss in the irradiated ear, both conductive and/or sensorineural. The contralateral ear remained unaltered. The hearing loss was permanent in 6 patients (33%) and affected their quality of life. The data suggest that changes occur in the inner ear as well as in the auditory nerve and auditory brain stem with conventional irradiation schemes with daily fractions of 2 to 2.5 Gy with a total dose of 50 Gy.

Entities:  

Mesh:

Year:  1994        PMID: 7977961     DOI: 10.1016/s0002-9610(05)80086-8

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  12 in total

1.  The effect of large single radiation doses on cochlear implant function: implications for radiosurgery.

Authors:  Thomas Klenzner; Johannes Lutterbach; Antje Aschendorff; Peter Pedersen; Mathias Stecker; Roland Laszig
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-09-18       Impact factor: 2.503

Review 2.  Organ-sparing radiation therapy for head and neck cancer.

Authors:  XiaoShen Wang; ChaoSu Hu; Avraham Eisbruch
Journal:  Nat Rev Clin Oncol       Date:  2011-07-26       Impact factor: 66.675

3.  Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients.

Authors:  Nicole E Marshall; Karla V Ballman; John C Michalak; Paula J Schomberg; Gary V Burton; Howard M Sandler; Terrence L Cascino; Kurt A Jaeckle; Jan C Buckner
Journal:  J Neurooncol       Date:  2006-05       Impact factor: 4.130

4.  Parotid carcinoma: Current diagnostic workup and treatment.

Authors:  Vincent L M Vander Poorten; Francis Marchal; Sandra Nuyts; Paul M J Clement
Journal:  Indian J Surg Oncol       Date:  2010-11-21

5.  Ototoxic effects of irradiation.

Authors:  I Upadhya; N Jariwala; J Datar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-02-23

6.  Localization of prestin and expression in the early period after radiation in mice.

Authors:  Chen Yang; Wei Zhang; Xiao-Long Liu; Yong Liang; Ya-Wei Yuan; Chen Ren; Jin-Hao Peng
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-07-17       Impact factor: 2.503

7.  Determining the prevalence of vestibular screening failures in pediatric cancer patients whose therapies include radiation to the head/neck and platin-based therapies: A pilot study.

Authors:  Miranda L Camet; Susan S Hayashi; Belinda C Sinks; Jennifer Henry; Katie Gettinger; Ashley Hite; Juliann Kiefer; Caroline Mohrmann; Taryn Sandheinrich; Feng Gao; Robert J Hayashi
Journal:  Pediatr Blood Cancer       Date:  2018-01-30       Impact factor: 3.167

8.  Cochlear Implant Outcomes: A Comparison between Irradiated and Non-irradiated Ears.

Authors:  Jie Min Soh; Vishal Deepak D'Souza; Gopal Krishna Sarepaka; Win Nie Ng; Chun Suan Ong; Wong Kein Low
Journal:  Clin Exp Otorhinolaryngol       Date:  2012-04-30       Impact factor: 3.372

9.  Audiometric patterns in ototoxicity after radiotherapy and chemotherapy in patients of head and neck cancers.

Authors:  Monika Shamrao Malgonde; P S Nagpure; Manoj Kumar
Journal:  Indian J Palliat Care       Date:  2015 May-Aug

10.  Highly Conformal Craniospinal Radiotherapy Techniques Can Underdose the Cranial Clinical Target Volume if Leptomeningeal Extension through Skull Base Exit Foramina is not Contoured.

Authors:  D J Noble; T Ajithkumar; J Lambert; I Gleeson; M V Williams; S J Jefferies
Journal:  Clin Oncol (R Coll Radiol)       Date:  2017-03-18       Impact factor: 4.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.